<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">codeine</td><td>Codeine</td><td ID="reaction1">headaches, nausea</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">1000 CBC W/AUTO DIFF</span><br/>Reviewed date:[REDACTED] 07:38:08 AM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/>PT FASTING</td></tr><tr><td ID="result1_attr1">WBC</td><td>3.9</td><td>3.5-11.0 K/UL</td><td/></tr><tr><td ID="result1_attr2">RBC</td><td>5.28</td><td>4.50-6.10 M/UL</td><td/></tr><tr><td ID="result1_attr3">HEMOGLOBIN</td><td>14.9</td><td>13.5-17.0 G/DL</td><td/></tr><tr><td ID="result1_attr4">HEMATOCRIT</td><td>45.6</td><td>40.0-51.0 %</td><td/></tr><tr><td ID="result1_attr5">MCV</td><td>86.4</td><td>80.0-99.0 fL</td><td/></tr><tr><td ID="result1_attr6">MCH</td><td>28.2</td><td>25.0-33.0 PG</td><td/></tr><tr><td ID="result1_attr7">MCHC</td><td>32.7</td><td>31.0-36.0 G/DL</td><td/></tr><tr><td ID="result1_attr8">RDW</td><td>15.1</td><td>11.5-15.0 %</td><td/></tr><tr><td ID="result1_attr9">NEUTROPHILS</td><td>60.8</td><td/><td/></tr><tr><td ID="result1_attr10">LYMPHOCYTES</td><td>27.7</td><td/><td/></tr><tr><td ID="result1_attr11">MONOCYTES</td><td>9.4</td><td/><td/></tr><tr><td ID="result1_attr12">EOSINOPHILS</td><td>1.8</td><td/><td/></tr><tr><td ID="result1_attr13">BASOPHILS</td><td>0.3</td><td/><td/></tr><tr><td ID="result1_attr14">IMMATURE GRANULOCYTES</td><td>0.0</td><td/><td/></tr><tr><td ID="result1_attr15">NUCLEATED RBCS</td><td>0.0</td><td>0.0  /100 WBC'S</td><td/></tr><tr><td ID="result1_attr16">PLATELET COUNT</td><td>278</td><td>130-400 K/UL</td><td/></tr><tr><td ID="result1_attr17">ABSOLUTE NEUTROPHILS</td><td>2.40</td><td>1.50-7.50 K/UL</td><td/></tr><tr><td ID="result1_attr18">ABSOLUTE LYMPHOCYTES</td><td>1.09</td><td>1.00-4.00 K/UL</td><td/></tr><tr><td ID="result1_attr19">ABSOLUTE MONOCYTES</td><td>0.37</td><td>0.20-1.00 K/UL</td><td/></tr><tr><td ID="result1_attr20">ABSOLUTE EOSINOPHILS</td><td>0.07</td><td>0.00-0.50 K/UL</td><td/></tr><tr><td ID="result1_attr21">ABSOLUTE BASOPHILS</td><td>0.01</td><td>0.00-0.20 K/UL</td><td/></tr><tr><td ID="result1_attr22">ABS IMMATURE GRANULOCYTES</td><td>0.00</td><td>0.00-0.10 K/UL</td><td/></tr><tr><td ID="result1_attr23">ABS NUCLEATED RBCS</td><td>0.00</td><td>0.00-0.11 K/UL</td><td/></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL + e-GFR</span><br/>Reviewed date:[REDACTED] 07:38:08 AM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/>PT FASTING</td></tr><tr><td ID="result2_attr1">GLUCOSE</td><td>90</td><td>70-99 MG/DL</td><td/></tr><tr><td ID="result2_attr2">BUN</td><td>18</td><td>8-23 MG/DL</td><td/></tr><tr><td ID="result2_attr3">CREATININE</td><td>1.27</td><td>0.80-1.40 MG/DL</td><td/></tr><tr><td ID="result2_attr4">eGFR (2021 CKD-EPI)</td><td>60</td><td>&gt;60 ML/MIN/1.73</td><td/></tr><tr><td ID="result2_attr5">CALC BUN/CREAT</td><td>14</td><td>6-28 RATIO</td><td/></tr><tr><td ID="result2_attr6">SODIUM</td><td>141</td><td>133-146 MEQ/L</td><td/></tr><tr><td ID="result2_attr7">POTASSIUM</td><td>5.0</td><td>3.5-5.4 MEQ/L</td><td/></tr><tr><td ID="result2_attr8">CHLORIDE</td><td>105</td><td>95-107 MEQ/L</td><td/></tr><tr><td ID="result2_attr9">CARBON DIOXIDE</td><td>27</td><td>19-31 MEQ/L</td><td/></tr><tr><td ID="result2_attr10">CALCIUM</td><td>9.7</td><td>8.5-10.5 MG/DL</td><td/></tr><tr><td ID="result2_attr11">PROTEIN, TOTAL</td><td>6.4</td><td>6.1-8.3 G/DL</td><td/></tr><tr><td ID="result2_attr12">ALBUMIN</td><td>4.4</td><td>3.5-5.2 G/DL</td><td/></tr><tr><td ID="result2_attr13">CALC GLOBULIN</td><td>2.0</td><td>1.9-3.7 G/DL</td><td/></tr><tr><td ID="result2_attr14">CALC A/G RATIO</td><td>2.2</td><td>1.0-2.6 RATIO</td><td/></tr><tr><td ID="result2_attr15">BILIRUBIN, TOTAL</td><td>0.3</td><td>&lt;=1.2 MG/DL</td><td/></tr><tr><td ID="result2_attr16">ALKALINE PHOSPHATASE</td><td>64</td><td>40-125 U/L</td><td/></tr><tr><td ID="result2_attr17">AST</td><td>19</td><td>9-50 U/L</td><td/></tr><tr><td ID="result2_attr18">ALT</td><td>21</td><td>5-50 U/L</td><td ID="result2_attr18_notes"><p/><p>              UNLESS OTHERWISE INDICATED, ALL TESTING PERFORMED AT</p><p>       CLINICAL PATHOLOGY LABORATORIES, INC.  [REDACTED]</p><p>                 LABORATORY DIRECTOR:  [REDACTED], M.D.</p><p>            CLIA NUMBER 45D0505003  CAP ACCREDITATION NO. 21525-01</p></td></tr><tr><td colspan="4"><span class="content_span">2836 TSH + FREE T4 PROFILE</span><br/>Reviewed date:[REDACTED] 07:38:08 AM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/>PT FASTING</td></tr><tr><td ID="result3_attr1">TSH, THIRD GENERATION</td><td>0.605</td><td>0.400-4.100 UIU/ML</td><td/></tr><tr><td ID="result3_attr2">FREE T4 (THYROXINE)</td><td>1.20</td><td>0.80-1.90 NG/DL</td><td/></tr><tr><td colspan="4"><span class="content_span">173 LIPID PANEL</span><br/>Reviewed date:[REDACTED] 07:38:08 AM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/>PT FASTING</td></tr><tr><td ID="result4_attr1">CHOLESTEROL</td><td>131</td><td>&lt;200 MG/DL</td><td/></tr><tr><td ID="result4_attr2">TRIGLYCERIDES</td><td>48</td><td>&lt;150 MG/DL</td><td/></tr><tr><td ID="result4_attr3">HDL CHOLESTEROL</td><td>88</td><td>&gt;39 MG/DL</td><td/></tr><tr><td ID="result4_attr4">CALC LDL CHOL</td><td>29</td><td>&lt;100 MG/DL</td><td ID="result4_attr4_notes"><p/><p>NOTE: CALCULATED LDL IS BASED ON [REDACTED] METHOD WHICH</p><p>INCLUDES ADJUSTABLE TRIGLYCERIDE:VLDL CHOLESTEROL RATIO.</p><p>THIS FACTOR VARIES BY MEASURED TRIGLYCERIDE AND NON-HDL</p><p>CHOLESTEROL CONCENTRATIONS WITH INCREASED CALCULATED LDL SEEN</p><p>IN HIGHER TRIGLYCERIDE OR LOWER NON-HDL SPECIMENS. FOR MORE</p><p>INFORMATION, SEE CLIENT ANNOUNCEMENT AT</p><p>http://www.cpllabs.com/CalcLDL-C</p></td></tr><tr><td ID="result4_attr5">RISK RATIO LDL/HDL</td><td>0.33</td><td>&lt;3.55 RATIO</td><td/></tr><tr><td colspan="4"><span class="content_span">[REDACTED]</span><br/>Reviewed date:[REDACTED] 07:38:08 AM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/>PT FASTING</td></tr><tr><td ID="result5_attr1">HEMOGLOBIN A1c</td><td>6.0</td><td>4.2-5.6 %</td><td ID="result5_attr1_notes"><p/><p>         AMERICAN DIABETES ASSOCIATION GUIDELINES FOR HGB A1C:</p><p>          PREDIABETES/INCREASED RISK . . . . . . . 5.7-6.4%</p><p>          DIAGNOSIS OF DIABETES  . . . . . . . . . &gt;=6.5%</p><p>            WITH CONFIRMATION OR APPROPRIATE SYMPTOMS</p><p>     NOTE: ASSAY MAY BE AFFECTED BY HEMOGLOBINOPATHIES (SICKLE</p><p>     CELL ANEMIA, S-C DISEASE, OTHERS) OR ARTIFICIALLY LOWERED BY</p><p>     DECREASED RED CELL SURVIVAL (HEMOLYTIC ANEMIAS, BLOOD LOSS,</p><p>     ETC.).  CONSIDER ALTERNATE TESTING OR LABORATORY CONSULTATION.</p></td></tr><tr><td colspan="4"><span class="content_span">1505 URINALYSIS WITH MICROSCOPIC</span><br/>Reviewed date:[REDACTED] 07:38:08 AM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/>PT FASTING</td></tr><tr><td ID="result6_attr1">COLOR</td><td>YELLOW</td><td>YELLOW-STRAW</td><td/></tr><tr><td ID="result6_attr2">APPEARANCE</td><td>CLEAR</td><td>CLEAR</td><td/></tr><tr><td ID="result6_attr3">SPECIFIC GRAVITY</td><td>1.018</td><td>1.005-1.035</td><td/></tr><tr><td ID="result6_attr4">LEUKOCYTE ESTERASE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr5">NITRITE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr6">pH</td><td>5.5</td><td>5.0-9.0</td><td/></tr><tr><td ID="result6_attr7">PROTEIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr8">GLUCOSE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr9">KETONES</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr10">UROBILINOGEN</td><td>0.2</td><td>&lt;=2.0  MG/DL</td><td/></tr><tr><td ID="result6_attr11">BILIRUBIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr12">OCCULT BLOOD</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result6_attr13">WHITE BLOOD CELLS</td><td>0-5</td><td>0-5  /HPF</td><td/></tr><tr><td ID="result6_attr14">RED BLOOD CELLS</td><td>0-2</td><td>0-2  /HPF</td><td/></tr><tr><td ID="result6_attr15">EPITHELIAL CELLS</td><td>0-5</td><td>0-5  /HPF</td><td/></tr><tr><td ID="result6_attr16">BACTERIA</td><td>NONE SEEN</td><td>NONE SEEN</td><td/></tr><tr><td ID="result6_attr17">CASTS, HYALINE</td><td>NONE SEEN</td><td>NONE-TRACE</td><td/></tr><tr><td colspan="4"><span class="content_span">2606 PSA, TOTAL</span><br/>Reviewed date:[REDACTED] 07:38:08 AM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/>PT FASTING</td></tr><tr><td ID="result7_attr1">PSA, TOTAL</td><td>9.18</td><td>&lt;=4.00 NG/ML</td><td ID="result7_attr1_notes"><p/><p>   NOTE: Methodology is Roche Cobas Electrochemiluminescence</p><p>   Immunoassay traceable to WHO reference standard 96/760.</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Screening Colonoscopy | Please call pt. to schedule appt. and fax over procedure report once completed.</td></tr><tr><th>Diagnosis 1</th><td>Colon cancer screening (Z12.11)</td></tr><tr><th>Referral Organization</th><td>MCM Baytown [REDACTED] PCP</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>Cheruiyot</td></tr><tr><th>Referring Provider Speciality</th><td>Nurse Practitioner</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Gastroenterology</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 08:58:13 AM &gt;REFERRAL LAB AND FACE SHEET FAXED, PLEASE CALL PATIENT FOR A APPOINTMENT</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Evaluate and Treatment | Please call pt. to schedule appt. and fax over SOAP notes from OV consultation(s).</td></tr><tr><th>Diagnosis 1</th><td>Generalized abdominal pain (R10.84)</td></tr><tr><th>Referral Organization</th><td>MCM Baytown [REDACTED] PCP</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>Cheruiyot</td></tr><tr><th>Referring Provider Speciality</th><td>Nurse Practitioner</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Gastroenterology</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Evaluate and Treatment | Please refer pt. to Cardiologist of choice; [REDACTED], MD . Phone #: [REDACTED]</td></tr><tr><th>Diagnosis 1</th><td>Atrial fibrillation, persistent (I48.19)</td></tr><tr><th>Referral Organization</th><td>MCM Baytown [REDACTED] PCP</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>Cheruiyot</td></tr><tr><th>Referring Provider Speciality</th><td>Nurse Practitioner</td></tr><tr><th>Referred Provider Specialty</th><td>Cardiology</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Evaluate and Treatment</td></tr><tr><th>Diagnosis 1</th><td>Generalized abdominal pain (R10.84)</td></tr><tr><th>Diagnosis 2</th><td>Hepatic cyst (K76.89)</td></tr><tr><th>Referral Organization</th><td>MCM Baytown [REDACTED] PCP</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>Cheruiyot</td></tr><tr><th>Referring Provider Speciality</th><td>Nurse Practitioner</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Gastroenterology</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 03:26:22 PM &gt;REF HAS BEEN FAXED PLEASE CALL PATIENT</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Tamsulosin HCl 0.4 MG</td><td ID="instruction1">TAKE 1 CAPSULE BY MOUTH ONCE DAILY WITH SUPPER Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Eliquis 5 MG</td><td ID="instruction2">TAKE 1 TABLET BY MOUTH TWICE DAILY Oral for 45 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Omeprazole 20 MG</td><td ID="instruction3">1 capsule 30 minutes before morning meal Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication4">Sucralfate 1 GM</td><td ID="instruction4">1 tablet on an empty stomach Orally Twice a day for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication5">Docusate Sodium 100 MG</td><td ID="instruction5">TAKE 1 CAPSULE BY MOUTH TWICE DAILY Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Metoprolol Succinate ER 25 MG</td><td ID="instruction6">1 tablet Orally Once a day for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication7">Losartan Potassium 25 MG</td><td ID="instruction7">1 tablet Orally EVERY 12 HOURS for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div>No Information</div><h3><a name="id6" href="#toc">Social History</a></h3><div>No Information</div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>234467004</td><td ID="Problem1">Other thrombophilia (D68.69)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems1notes">eliquis</td></tr><tr><td>Problem</td><td>104931000119100</td><td ID="Problem2">Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (I12.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems2notes"><p>cont on amlodipine ( not sure of the dose, pt will call us) started by cardiologist</p><p>---On Losartan 25mg q 12 h and Metoprolol succ ER 25 mg daily</p></td></tr><tr><td>Problem</td><td>266435005</td><td ID="Problem3">GERD without esophagitis (K21.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems3notes"><p>----CONT ON OMEPRAZOLE 20mg </p><p>----START CARAFATE 1G AS DIRECTED </p><p>---IF MED NOT EFFECTIVE, REFER TO GI</p></td></tr><tr><td>Problem</td><td>431856006</td><td ID="Problem4">CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min (N18.2)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems4notes"><p>Avoid</p><p>Nephrotoxic including NSAIDS and other toxic medications, continue good</p><p>hydration.Monitor.</p></td></tr><tr><td>Problem</td><td>85057007</td><td ID="Problem5">Hepatic cyst (K76.89)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems5notes">---4MM HEPATIC CYST PER MRI ABDOMEN [REDACTED]</td></tr><tr><td>Problem</td><td>390951007</td><td ID="Problem6">IFG (impaired fasting glucose) (R73.01)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems6notes"><p>A1C 6.0 H </p><p>MONITOR AND CONT LOW CARB/SUGAR DIWT.</p></td></tr><tr><td>Problem</td><td>Bladder cancer (399326009)</td><td ID="Problem7">BLADDER CANCER (C67.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems7notes">.ESTABLISHED WITH ONCOLOGIST</td></tr><tr><td>Problem</td><td>Benign prostatic hypertrophy without outflow obstruction (254902007)</td><td ID="Problem8">BPH (benign prostatic hypertrophy) (N40.0)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems8notes"><p>CONT ON TAMSULOSIN, STABLE</p><p>established with urologist</p></td></tr><tr><td>Problem</td><td>Persistent atrial fibrillation (440059007)</td><td ID="Problem9">Atrial fibrillation, persistent (I48.19)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems9notes"><p>STABLE, ON ELIQUIS</p><p>ESTABLISHED WITH CARDIOLOGIST</p></td></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>65 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital2">Temperature</th><td>98.6 degrees Fahrenheit</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital3">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital4">Height-cm</th><td>172.72 cm</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital5">Oximetry</th><td>99 %</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital6">Blood pressure diastolic</th><td>94 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital7">Weight-kg</th><td>79.38 kg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital8">Height</th><td>68 in</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital9">Blood pressure systolic</th><td>130 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital10">Weight</th><td>175.0 lbs</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital11">BMI</th><td>26.61 kg/m2</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9</td></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertension, essential I10 ; Screening for blood or protein in urine Z13.89 ; Screening cholesterol level Z13.220 ; Screening for diabetes mellitus Z13.1 ; Screening for metabolic disorder Z13.228 ; Screening, deficiency anemia, iron Z13.0 ; SCREENING FOR THYROID DISORDER Z13.29 and SCREENING FOR PROSTATE CANCER Z12.5</td></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Encounter for general adult medical examination without abnormal findings Z00.00 ; CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min N18.2 ; Atrial fibrillation, persistent I48.19 ; BPH (benign prostatic hypertrophy) N40.0 ; BLADDER CANCER C67.9 ; IFG (impaired fasting glucose) R73.01 ; Elevated PSA R97.20 ; Colon cancer screening Z12.11 and Other thrombophilia D68.69</td></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Right sided abdominal pain R10.9 ; CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min N18.2 and BPH (benign prostatic hypertrophy) N40.0</td></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min N18.2 ; GERD without esophagitis K21.9 and Atrial fibrillation, persistent I48.19</td></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Generalized abdominal pain R10.84 ; CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min N18.2 ; GERD without esophagitis K21.9 and Atrial fibrillation, persistent I48.19</td></tr><tr><td>MCM Baytown [REDACTED] PCP</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Generalized abdominal pain R10.84 ; Renal cell adenoma of right kidney D30.01 ; Hepatic cyst K76.89 ; Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min N18.2 ; SCREENING FOR PROSTATE CANCER Z12.5 ; ENCOUNTER FOR VITAMIN DEFICIENCY SCREENING Z13.21 and SCREENING FOR DIABETES MELLITUS Z13.1</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Hypertension, essential (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Screening for blood or protein in urine (ICD-10 - Z13.89)</td><td/><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CONT ON VALSARTAN AND LOW SALT DIET.</td><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Encounter for general adult medical examination without abnormal findings (ICD-10 - Z00.00)</td><td/><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>UNSTABLE...CONT ON METOPROLOL 25MG QD  AND LOSARTAN 25MG Q 12 

</td><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Right sided abdominal pain (ICD-10 - R10.9)</td><td>CT of the abdomen and pelvis no contrast</td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CONT ON METOPROLOL 25MG QD  AND LOSARTAN 25MG Q 12</td><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min (ICD-10 - N18.2)</td><td>AVOID NEPHROTOXIC DRUGS, CONT GOOD HYDRATION, MONITOR.</td><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CONT ON METOPROLOL 25MG QD  AND LOSARTAN 25MG Q 12</td><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Generalized abdominal pain (ICD-10 - R10.84)</td><td><p>refer for an MRI w/o contrast</p><p>--refer to GI </p></td><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CONT ON METOPROLOL 25MG QD  AND LOSARTAN 25MG Q 12</td><td/><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Generalized abdominal pain (ICD-10 - R10.84)</td><td><p>REFER TO GI </p><p>---MRI COMPLETED [REDACTED] AND IT SHOWS RIGHT RENAL ADENOMA 1.2CM AND 4MM HEPATIC CYST </p><p>----CT WAS COMPLETED  AND IT WAS NEGATIVE</p></td><td/><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Renal cell adenoma of right kidney (ICD-10 - D30.01)</td><td>1.2CM ADENOMA  PER MRI ABDOMEN [REDACTED]</td><td/><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Hepatic cyst (ICD-10 - K76.89)</td><td>---4MM HEPATIC CYST PER MRI ABDOMEN [REDACTED]</td><td/><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min (ICD-10 - N18.2)</td><td>AVOID NEPHROTOXIC DRUGS, CONT GOOD HYDRATION, MONITOR.</td><td/><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>GERD without esophagitis (ICD-10 - K21.9)</td><td><p>----CONT ON OMEPRAZOLE 20mg </p><p>----START CARAFATE 1G AS DIRECTED </p><p>---IF MED NOT EFFECTIVE, REFER TO GI</p></td><td/><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min (ICD-10 - N18.2)</td><td>AVOID NEPHROTOXIC DRUGS, CONT GOOD HYDRATION, MONITOR.</td><td/><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min (ICD-10 - N18.2)</td><td>AVOID NEPHROTOXIC DRUGS, CONT GOOD HYDRATION, MONITOR.</td><td/><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Screening cholesterol level (ICD-10 - Z13.220)</td><td/><td/><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Screening for diabetes mellitus (ICD-10 - Z13.1)</td><td/><td/><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Atrial fibrillation, persistent (ICD-10 - I48.19)</td><td><p>STABLE, ON ELIQUIS</p><p>ESTABLISHED WITH CARDIOLOGIST</p></td><td/><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>BPH (benign prostatic hypertrophy) (ICD-10 - N40.0)</td><td><p>CONT ON TAMSULOSIN, STABLE</p><p>established with urologist</p></td><td/><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Atrial fibrillation, persistent (ICD-10 - I48.19)</td><td><p>STABLE, ON ELIQUIS</p><p>ESTABLISHED WITH CARDIOLOGIST</p></td><td/><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>GERD without esophagitis (ICD-10 - K21.9)</td><td><p>----CONT ON OMEPRAZOLE 20mg </p><p>----START CARAFATE 1G AS DIRECTED </p><p>---IF MED NOT EFFECTIVE, REFER TO GI</p></td><td/><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td><p>cont on amlodipine ( not sure of the dose, pt will call us) started by cardiologist</p><p>---On Losartan 25mg q 12 h and Metoprolol succ ER 25 mg daily</p></td><td/><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min (ICD-10 - N18.2)</td><td><p>Avoid</p><p>Nephrotoxic including NSAIDS and other toxic medications, continue good</p><p>hydration.Monitor.</p></td><td/><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Atrial fibrillation, persistent (ICD-10 - I48.19)</td><td><p>STABLE, ON ELIQUIS</p><p>ESTABLISHED WITH CARDIOLOGIST</p></td><td/><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>BPH (benign prostatic hypertrophy) (ICD-10 - N40.0)</td><td>CONT ON TAMSULOSIN, STABLE</td><td/><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Screening for metabolic disorder (ICD-10 - Z13.228)</td><td/><td/><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>BLADDER CANCER (ICD-10 - C67.9)</td><td>.ESTABLISHED WITH ONCOLOGIST</td><td/><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>Screening, deficiency anemia, iron (ICD-10 - Z13.0)</td><td/><td/><td/></tr><tr><td ID="ref32">[REDACTED]</td><td>SCREENING FOR PROSTATE CANCER (ICD-10 - Z12.5)</td><td/><td/><td/></tr><tr><td ID="ref33">[REDACTED]</td><td>ENCOUNTER FOR VITAMIN DEFICIENCY SCREENING (ICD-10 - Z13.21)</td><td/><td/><td/></tr><tr><td ID="ref34">[REDACTED]</td><td>SCREENING FOR THYROID DISORDER (ICD-10 - Z13.29)</td><td/><td/><td/></tr><tr><td ID="ref35">[REDACTED]</td><td>IFG (impaired fasting glucose) (ICD-10 - R73.01)</td><td><p>A1C 6.0 H </p><p>MONITOR AND CONT LOW CARB/SUGAR DIWT.</p></td><td/><td/></tr><tr><td ID="ref36">[REDACTED]</td><td>Elevated PSA (ICD-10 - R97.20)</td><td>REFER TO UROLOGIST, MONITOR.</td><td/><td/></tr><tr><td ID="ref37">[REDACTED]</td><td>SCREENING FOR PROSTATE CANCER (ICD-10 - Z12.5)</td><td/><td/><td/></tr><tr><td ID="ref38">[REDACTED]</td><td>SCREENING FOR DIABETES MELLITUS (ICD-10 - Z13.1)</td><td/><td/><td/></tr><tr><td ID="ref39">[REDACTED]</td><td>Colon cancer screening (ICD-10 - Z12.11)</td><td>REFER FOR COLONOSCOPY</td><td/><td/></tr><tr><td ID="ref40">[REDACTED]</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td>eliquis</td><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">CT Scan : Abdomen and Pelvis without contrast material 74176</td><td>[REDACTED]</td></tr><tr><td ID="futureTest2">MRI : Abdomen without Contrast (74181)</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 09:30:00 AM, [REDACTED][REDACTED]-3385, [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Devoted HMO Health Plan</td><td>PO BOX 211524 [REDACTED][REDACTED]-2724</td><td>[REDACTED]</td><td>DK5ERZ</td><td/><td>[REDACTED]</td><td>Self - patient is the insured</td><td/><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>poor historian---cystoscopy</td><td/></tr></tbody></table><span class="content_span">Hospitalization History</span><table width="100%" border="1"><thead><tr><th>Reason</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>See surgeries</td><td/></tr></tbody></table></div><br/><br/>
</body></html>